120 related articles for article (PubMed ID: 12698552)
1. [Platelet inhibitors: old and new].
Lecompte T
Tunis Med; 2002; 80(8 Suppl):39-51. PubMed ID: 12698552
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Savi P; Herbert JM
Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
[TBL] [Abstract][Full Text] [Related]
3. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet agents in stroke prevention. combination therapy: present and future.
Weksler BB
Cerebrovasc Dis; 2000; 10 Suppl 5():41-8. PubMed ID: 11096182
[TBL] [Abstract][Full Text] [Related]
5. Aspirin in patients with coronary artery disease: is it simply irresistible?
Nair GV; Davis CJ; McKenzie ME; Lowry DR; Serebruany VL
J Thromb Thrombolysis; 2001 Apr; 11(2):117-26. PubMed ID: 11406726
[No Abstract] [Full Text] [Related]
6. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
Judge HM; Buckland RJ; Holgate CE; Storey RF
Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet agents.
Varon D; Spectre G
Hematology Am Soc Hematol Educ Program; 2009; ():267-72. PubMed ID: 20008209
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy.
Gershlick AH
Hosp Med; 2000 Jan; 61(1):15-23. PubMed ID: 10735148
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel.
Schrör K
Vasc Med; 1998; 3(3):247-51. PubMed ID: 9892518
[TBL] [Abstract][Full Text] [Related]
10. [Antiplatelet therapy].
Ikeda Y
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1802-11. PubMed ID: 10581767
[No Abstract] [Full Text] [Related]
11. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
12. Platelet P2 receptors: old and new targets for antithrombotic drugs.
Cattaneo M
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):45-55. PubMed ID: 17187456
[TBL] [Abstract][Full Text] [Related]
13. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
14. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
Mehta SR;
J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects of platelet inhibitors and thrombus formation.
Meadows TA; Bhatt DL
Circ Res; 2007 May; 100(9):1261-75. PubMed ID: 17495233
[TBL] [Abstract][Full Text] [Related]
16. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
Steinhubl S; Roe MT
Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
[TBL] [Abstract][Full Text] [Related]
17. Contemporary use of antiplatelet therapies in percutaneous coronary interventions.
Saw J; Moliterno DJ
Coron Artery Dis; 2003 Aug; 14(5):373-80. PubMed ID: 12878902
[No Abstract] [Full Text] [Related]
18. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL
JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379
[TBL] [Abstract][Full Text] [Related]
19. [New antiplatelet agents].
Diez-Ewald
Invest Clin; 2000 Sep; 41(3):147-8. PubMed ID: 11029831
[No Abstract] [Full Text] [Related]
20. Current oral antiplatelet agents to prevent atherothrombosis.
Hankey GJ
Cerebrovasc Dis; 2001; 11 Suppl 2():11-7. PubMed ID: 11316917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
